Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Bivision
company
About
Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).
- 11 - 50
Details
- Last Funding Type
- Angel
- Last Funding Money Raised
- ¥100M
- Industries
- Biopharma,Health Diagnostics
- Founded date
- Jan 1, 2021
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
Bivision has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Aug 10, 2022 from a Angel round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 10, 2022 | Angel | ¥100M | 3 |
Gaorong Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Bivision is funded by 3 investors.
Gaorong Capital
and Lichen Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Gaorong Capital
|
Yes | Angel |
|
|
— | Angel |
VI Ventures
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
